Presumptive therapy for bites and clenched-fist injuries
If presumptive antibiotic therapy is indicated for bite or clenched-fist injury injuries (see Principles of management of bites and clenched-fist injuries), use:
amoxicillin+clavulanate 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally, 12-hourly for 3 days1. For dosage adjustment in adults with kidney impairment, see amoxicillin+clavulanate oral dosage adjustment. amoxicillin + clavulanate amoxicillin+clavulanate amoxicillin+clavulanate
In the community setting, if there is likely to be a delay in accessing oral therapy, give an immediate dose of intramuscular procaine benzylpenicillin. Use:
procaine benzylpenicillin 1.5 g (child: 50 mg/kg up to 1.5 g) intramuscularly, as a single dose while awaiting oral therapy2. For dosage adjustment in adults with kidney impairment, see procaine benzylpenicillin dosage adjustment. procaine benzylpenicillin procaine benzylpenicillin procaine benzylpenicillin
Start continuation therapy with oral amoxicillin+clavulanate (see dosage above) as soon as it is available.
If oral absorption is likely to be impaired (eg following major trauma), use intravenous therapy:
2+0.2 g formulation
adult, or child 40 kg or more: 2+0.2 g 8-hourly. For dosage adjustment in adults with kidney impairment, see amoxicillin+clavulanate intravenous dosage adjustment
OR
1+0.2 g formulation
adult, or child 40 kg or more: 1+0.2 g 6-hourly. For dosage adjustment in adults with kidney impairment, see amoxicillin+clavulanate intravenous dosage adjustment
child 1 month to younger than 3 months and less than 4 kg: 25+5 mg/kg 12-hourly
child 1 month to younger than 3 months and 4 kg or more: 25+5 mg/kg 8-hourly
child 3 months or older and less than 40 kg: 25+5 mg/kg up to 1+0.2 g 8-hourly.
Switch to oral amoxicillin+clavulanate (see dosage above) as soon as oral absorption is adequate and oral therapy is tolerated.
For patients with hypersensitivity to penicillins, or at increased risk of methicillin-resistant Staphylococcus aureus (MRSA) infection (see Risk factors for infection with methicillin-resistant Staphylococcus aureus), for whom oral therapy is indicated, use:
metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly for 3 days metronidazole metronidazole metronidazole
PLUS EITHER
1doxycycline orally, 12-hourly for 3 days3 doxycycline doxycycline doxycycline
adult: 100 mg
child less than 21 kg: 2.2 mg/kg4
child 21 to less than 26 kg: 50 mg
child 26 to 35 kg: 75 mg
child more than 35 kg: 100 mg
OR
2trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, 12-hourly for 3 days. For dosage adjustment in adults with kidney impairment, see trimethoprim+sulfamethoxazole dosage adjustment. trimethoprim + sulfamethoxazole trimethoprim+sulfamethoxazole trimethoprim+sulfamethoxazole
For patients who report hypersensitivity to a penicillin who require intravenous or intramuscular therapy, seek expert advice.